(Q41474934)

1 October 2017

Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy (English)

1 reference

1 October 2017

1 reference

Li Shen

1

1 reference

PMC publication ID

3489755

1 October 2017

Roberto Pili

series ordinal

2

1 reference

1 October 2017

1 September 2012

1 reference

1 October 2017

1 reference

1 October 2017

1

1 reference

1 October 2017

6

1 reference

1 October 2017

948-950

1 reference

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

Deacetylase inhibition promotes the generation and function of regulatory T cells.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489755

IL-27 inhibits the development of regulatory T cells via STAT3

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FONCI.20306

21 January 2018

Identifiers

DOI

10.4161/ONCI.20306

1 reference

1 October 2017

1 reference

PMC publication ID

3489755

1 October 2017

PubMed publication ID

23162767

1 reference

PMC publication ID

3489755